Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 21, 2026
TickeronGET DAILY SIGNALS
SCHD vs TBG: Weighing Two Dividend ETF Strategies

SCHD vs TBG: Weighing Two Dividend ETF Strategies

Key Takeaways

  • SCHD is a low-cost, passively managed dividend ETF tracking the Dow Jones U.S. Dividend 100 Index, while TBG is an actively managed, concentrated dividend-growth portfolio.
  • Cost gap is significant: SCHD charges a 0.06% expense ratio versus roughly 0.59% for TBG, a structural advantage that compounds over time.
  • Diversification differs sharply: SCHD holds roughly 100 large-cap names, while TBG holds only about 35–40 positions and can include REITs (real estate investment trusts) and MLPs (master limited partnerships).
  • Sector exposure overlaps but tilts differently: both are value-heavy in healthcare, energy, and consumer staples, though TBG adds meaningful real estate and financials weight.
  • Liquidity and track record favor SCHD, which has operated since 2011 with deep trading volume, versus TBG's November 2023 launch and smaller asset base.
  • Tickeron AI Verdict: SCHD — superior cost efficiency, broader diversification, deeper liquidity, and a longer, more consistent operating history.

Why This Comparison Matters for Dividend Investors

Dividend-focused investors often weigh a rules-based index approach against an active, high-conviction strategy. SCHD and TBG both target U.S. companies with durable dividends, yet they rest on fundamentally different frameworks. They do not compete directly as clones; instead, they offer alternative paths toward similar goals of income and lower-volatility equity exposure. Comparing their structure, sector positioning, and cost profiles clarifies which vehicle suits different market environments and why relative positioning matters for long-term fund performance. I also checked this using Tickeron’s AI Screener to see how the two line up against broader industry peers.

A Closer Look at SCHD

SCHD is a passively managed ETF that tracks the Dow Jones U.S. Dividend 100 Index, selecting U.S. stocks with a record of consistent dividend payments and fundamental strength based on financial ratios. Launched in 2011, the fund holds approximately 100 large-cap securities and carries a 0.06% expense ratio, among the lowest in the dividend ETF category. Its largest positions include TXN, MRK, CVX, KO, HD, VZ, PG, and AMGN. Sector exposure is led by consumer staples (roughly 20%), healthcare (about 19%), energy (around 17%), and financials (about 9%), with a smaller technology footprint than broad-market funds. The index is reconstituted annually and reviewed quarterly, delivering transparent, systematic turnover with a large-value profile.

Understanding TBG’s Active Approach

TBG is an actively managed ETF launched in November 2023 and sub-advised by The Bahnsen Group. It seeks income and long-term capital appreciation by investing in roughly 35–40 U.S. companies believed to have the potential to grow dividends over time, and it may also hold REITs and MLPs. The fund carries a net expense ratio of approximately 0.59% and manages a comparatively small asset base. Top holdings include BX, MRK, VZ, CVX, PG, JNJ, and PEP. Its sector breakdown is led by healthcare (about 16%), energy (around 15%), consumer staples (near 14%), financials (roughly 13%), and real estate (about 12%), giving it more concentrated, valuation-driven exposure than SCHD and no binding index constraints.

The Industry and Thematic Backdrop

Both funds sit within the large-value, high-dividend segment of U.S. equities, a group that has drawn renewed attention as investors weigh interest-rate expectations, inflation persistence, and earnings breadth beyond mega-cap technology. Defensive sectors such as healthcare, consumer staples, and energy — heavily represented in both portfolios — tend to hold up in late-cycle or slowing-growth environments, while their dividend yields compete with cash and bond income as rate expectations shift. Energy names remain sensitive to commodity prices and geopolitical developments, while healthcare and staples are influenced by regulatory and pricing dynamics. For TBG, real estate and MLP exposure adds sensitivity to borrowing costs and energy infrastructure demand, creating a slightly different risk profile than SCHD's more traditional large-cap dividend mix.

Performance and Positioning: Key Differences

Over recent weeks and months, both funds have traded within the same broad value/dividend rotation, but their relative positioning has diverged in important ways. SCHD's broader, index-driven diversification and near-zero cost have supported steadier, benchmark-consistent behavior, with its technology and industrial weightings providing some cyclical balance. TBG's concentrated, active mandate has produced more idiosyncratic variation tied to its financials, energy, and real estate holdings, and its higher fee drags on net returns. In recent market cycles, low-cost passive dividend strategies have generally compounded more efficiently, while concentrated active funds require sustained manager skill to overcome the cost disadvantage. TBG's shorter history and smaller liquidity also introduce execution and tracking considerations that SCHD largely avoids.

Refining ETF Research with Tickeron Tools

From what I see in my own process, tools like Tickeron’s AI Screener help surface comparable dividend and value opportunities efficiently by applying customizable filters for industry, fundamentals, and technical signals. I find it useful for quickly narrowing the field before diving into detailed holdings and cost analysis, especially when evaluating how one fund stacks up against peers in the same category.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD, TBG

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SCHD sees MACD Histogram crosses below signal line

SCHD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 29 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 50 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

SCHD moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.

Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 285 of 363 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), PepsiCo (NASDAQ:PEP), Abbott Laboratories (NYSE:ABT).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 57.94B. The market cap for tickers in the group ranges from 363.12M to 417.06B. CVX holds the highest valuation in this group at 417.06B. The lowest valued company is AMSF at 363.12M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -6%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 5%. GIS experienced the highest price growth at 4%, while VRTS experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 58%. For the same stocks of the ETF, the average monthly volume growth was 35% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 42
Price Growth Rating: 48
SMR Rating: 42
Profit Risk Rating: 60
Seasonality Score: 9 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.